GO:0034983 peptidyl-lysine deacetylation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034983 peptidyl-lysine deacetylation is the biological process that removes an acetyl group from an acetylated lysine residue in a peptide or protein.
• This process is the reverse of lysine acetylation and is central to dynamic regulation of protein function, including in bacteria where acetylation affects antibiotic resistance.
• Lysine acetylation and deacetylation are conserved post-translational modifications that influence enzyme activity, protein stability, and interactions.
• In Escherichia coli, lysine acetylation is widespread and has been linked to antibiotic resistance phenotypes.
• Studying peptidyl-lysine deacetylation requires integrating genetic, biochemical, and proteomic approaches to identify substrates and regulatory enzymes.
• CRISPR-based models enable causal testing of deacetylase genes and their roles in cellular processes and disease.
Description
Peptidyl-lysine deacetylation (GO:0034983) is a fundamental biological process that removes acetyl groups from lysine residues on proteins, reversing the effects of lysine acetylation. This dynamic modification is part of the broader landscape of post-translational regulation that controls protein activity, localization, and interactions in both prokaryotes and eukaryotes. In bacteria such as Escherichia coli, lysine acetylation is increasingly recognized as a key regulatory mechanism, and its interplay with deacetylation influences phenotypes including antibiotic resistance. Understanding peptidyl-lysine deacetylation is therefore critical for researchers investigating cellular signaling, microbial physiology, and potential therapeutic targets.
peptidyl-lysine deacetylation At A Glance
| GO ID | GO:0034983 |
|---|---|
| GO term | peptidyl-lysine deacetylation |
| Ontology | biological_process |
| Synonym | protein lysine acetylation |
| Definition | The removal of an acetyl group from an acetylated lysine residue in a peptide or protein. |
| Major function | Reverses lysine acetylation to regulate protein activity, stability, and interactions. |
| Related process | Protein post-translational modification; lysine acetylation/deacetylation cycle. |
| Taxonomic scope | Conserved from bacteria to humans. |
| Example organism | Escherichia coli, where lysine acetylation influences antibiotic resistance. |
What Is GO:0034983?
According to the Gene Ontology, peptidyl-lysine deacetylation (GO:0034983) is defined as the removal of an acetyl group from an acetylated lysine residue in a peptide or protein. This process is the enzymatic counterpart to lysine acetylation and is mediated by deacetylase enzymes that hydrolyze the amide bond between the acetyl group and the epsilon-amino group of lysine. It is a biological process that contributes to the reversible regulation of protein function and is conserved across taxa.
Why Is peptidyl-lysine deacetylation Important in Cell Biology?
Peptidyl-lysine deacetylation is important because it provides a reversible switch for controlling protein function, allowing cells to rapidly respond to environmental and metabolic cues. In bacteria, this process contributes to phenotypes such as antibiotic resistance, making it a potential target for new therapeutic strategies. In higher organisms, deacetylation is implicated in gene expression, cell cycle progression, and stress responses, underscoring its broad biological significance.
• Reverses lysine acetylation, enabling dynamic regulation of protein function.
• Influences antibiotic resistance in bacteria such as Escherichia coli.
• Modulates enzyme activity and protein-protein interactions.
• Plays a role in cellular responses to environmental stress.
• Contributes to metabolic regulation and energy homeostasis.
• Is a potential target for antimicrobial and anticancer therapies.
• Provides a mechanism for epigenetic-like regulation in prokaryotes.
• Essential for maintaining proteome integrity and function.
What Happens During peptidyl-lysine deacetylation?
Recognition of Acetylated Lysine Substrates
In simple terms: The deacetylase enzyme finds and binds to proteins that have an acetyl group attached to a lysine.
Deacetylases recognize acetylated lysine residues within specific sequence contexts or structural motifs. In Escherichia coli, lysine acetylation is widespread, and deacetylases must distinguish acetylated substrates from non-acetylated proteins to ensure specificity. This recognition step is critical for targeting the correct proteins and avoiding off-target effects.
Catalytic Removal of the Acetyl Group
In simple terms: The enzyme chemically cuts the acetyl group off the lysine.
The deacetylation reaction involves hydrolysis of the amide bond between the acetyl group and the lysine side chain, releasing acetate and regenerating the unmodified lysine. This catalytic step is often dependent on metal ions or cofactors, although the exact mechanism varies among deacetylase families. In bacteria, this reaction contributes to the dynamic acetylation landscape that affects antibiotic resistance.
Release of Deacetylated Protein and Acetate
In simple terms: The protein is released without the acetyl group, and the acetyl group is discarded as acetate.
Following catalysis, the deacetylated protein is released, and the acetyl group is converted to acetate, which can be recycled or excreted. The deacetylated protein may then adopt altered activity, stability, or interactions, thereby propagating downstream effects. This step completes the deacetylation cycle and allows the protein to re-enter regulatory pathways.
Integration with Cellular Metabolism
In simple terms: The products of deacetylation feed back into the cell's metabolism.
Acetate produced by deacetylation can be used in metabolic pathways, linking protein deacetylation to central metabolism. In Escherichia coli, this integration may influence growth and survival under antibiotic stress. Thus, peptidyl-lysine deacetylation is not an isolated event but part of a broader metabolic network.
Key Genes Involved in GO:0034983 peptidyl-lysine deacetylation
The following genes and proteins are involved in peptidyl-lysine deacetylation or its regulation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CobB | NAD+-dependent deacetylase in E. coli | Model for bacterial deacetylation and antibiotic resistance |
| PatZ | Acetyltransferase that opposes deacetylation | Regulates acetylation levels in E. coli |
| AckA | Acetate kinase, links acetate metabolism to acetylation | Influences deacetylation substrate availability |
| Pta | Phosphate acetyltransferase, acetate metabolism | Affects acetyl-CoA pools for acetylation |
| RcsB | Response regulator, acetylation target | Substrate for deacetylation in signaling |
| CheY | Chemotaxis regulator, acetylation target | Model for deacetylation in signal transduction |
| EF-Tu | Translation elongation factor, acetylated | Deacetylation may affect translation |
| GroEL | Chaperonin, acetylated | Deacetylation impacts protein folding |
| DnaK | Chaperone, acetylated | Deacetylation in stress response |
| RNA polymerase subunits | Transcription machinery, acetylated | Deacetylation regulates transcription |
| Ribosomal proteins | Translation, acetylated | Deacetylation affects ribosome function |
| Metabolic enzymes | Various metabolic pathways | Deacetylation modulates enzyme activity |
| Antibiotic resistance proteins | Resistance mechanisms | Deacetylation may alter resistance phenotypes |
| Sirtuins (eukaryotic homologs) | NAD+-dependent deacetylases | Conserved deacetylation machinery |
| HDACs (eukaryotic homologs) | Zinc-dependent deacetylases | Conserved deacetylation machinery |
How Is peptidyl-lysine deacetylation Regulated?
Peptidyl-lysine deacetylation is regulated by the availability of acetyl-CoA and NAD+, the expression and activity of deacetylases and acetyltransferases, and cellular metabolic status. In Escherichia coli, acetylation levels are influenced by central metabolic enzymes such as AckA and Pta, which affect acetyl-CoA pools. Additionally, environmental stresses, including antibiotic exposure, can alter the acetylation/deacetylation balance, thereby modulating resistance phenotypes.
peptidyl-lysine deacetylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CobB | Antibiotic resistance in E. coli | Knockout and overexpression in E. coli |
| PatZ | Acetylation balance in bacteria | Point mutation of catalytic residues |
| HDACs | Cancer (eukaryotic) | Knockout in cancer cell lines |
| Sirtuins | Metabolic and aging-related diseases | Knock-in of human variants in model organisms |
Antibiotic Resistance in Bacterial Infections
Lysine acetylation and deacetylation have been implicated in antibiotic resistance in Escherichia coli, suggesting that targeting deacetylases could restore sensitivity to antibiotics. This link highlights the potential of deacetylation enzymes as therapeutic targets in infectious diseases.
Cancer and Eukaryotic Deacetylases
In eukaryotes, histone deacetylases (HDACs) and sirtuins are well-known deacetylases that regulate gene expression and are implicated in cancer. Although the provided citation focuses on bacteria, the conserved nature of peptidyl-lysine deacetylation suggests relevance to eukaryotic disease mechanisms.
Metabolic Disorders
Because deacetylation is linked to acetyl-CoA and NAD+ metabolism, dysregulation of this process may contribute to metabolic disorders. Further research is needed to establish direct causal links in human diseases.
From peptidyl-lysine deacetylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CobB deacetylation affect antibiotic resistance? | CobB knockout in E. coli |
| What are the substrates of a deacetylase? | Tagged knock-in for proteomics |
| How does a point mutation in the catalytic site affect deacetylation? | Point mutation knock-in |
| Can overexpression of a deacetylase reverse acetylation phenotypes? | Overexpression cell model |
| Which genes regulate deacetylation globally? | CRISPR library screening |
| How does deacetylation change under antibiotic stress? | RNA-seq and proteomics |
How to Study the peptidyl-lysine deacetylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry | Acetylated lysine sites and stoichiometry | Substrate identification |
| Western blot with anti-acetyl-lysine | Global acetylation levels | Deacetylase activity assessment |
| Knockout models | Loss-of-function phenotypes | Causal gene testing |
| Overexpression | Gain-of-function effects | Rescue experiments |
| RNA-seq | Transcriptional changes | Pathway analysis |
| Antibiotic susceptibility assays | Resistance phenotypes | Bacterial deacetylation studies |
| In vitro deacetylation assays | Enzymatic activity | Kinetic characterization |
Proteomics for Acetylation Site Identification
Mass spectrometry-based proteomics can identify acetylated lysine residues and quantify changes upon deacetylase manipulation. This approach is essential for mapping substrates of peptidyl-lysine deacetylation.
Genetic Knockout and Knockdown
Knocking out candidate deacetylase genes, such as CobB in E. coli, allows researchers to assess the functional consequences of loss of deacetylation. Phenotypic assays, including antibiotic susceptibility testing, can then be performed.
Biochemical Deacetylation Assays
In vitro assays using purified enzymes and acetylated substrates can directly measure deacetylation activity. These assays help confirm enzyme specificity and kinetics.
Transcriptomics and Systems Biology
RNA-seq can reveal global transcriptional changes associated with altered deacetylation, providing insights into downstream pathways. Integrating transcriptomics with proteomics offers a systems-level view.
How CRISPR Can Be Used to Study GO:0034983 peptidyl-lysine deacetylation
Knockout
CRISPR knockout of deacetylase genes, such as CobB in E. coli, enables researchers to study the loss of peptidyl-lysine deacetylation and its impact on phenotypes like antibiotic resistance. Knockout models are essential for establishing causality.
Point Mutation
Introducing point mutations in catalytic residues of deacetylases via CRISPR can dissect the enzymatic contribution to deacetylation without completely abolishing protein expression. This approach helps distinguish catalytic from scaffolding functions.
Knock-in
Knock-in of tagged deacetylases allows for affinity purification and identification of interacting proteins and substrates. This is valuable for mapping the deacetylation network.
Overexpression
CRISPR activation or plasmid-based overexpression of deacetylases can test whether increased deacetylation reverses acetylation-dependent phenotypes. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports peptidyl-lysine deacetylation Research
Researchers studying peptidyl-lysine deacetylation-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as antibiotic resistance or metabolic regulation. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for peptidyl-lysine deacetylation research.
Frequently Asked Questions About peptidyl-lysine deacetylation
What is peptidyl-lysine deacetylation?
Peptidyl-lysine deacetylation (GO:0034983) is the biological process that removes an acetyl group from an acetylated lysine residue in a protein.
What genes are involved in peptidyl-lysine deacetylation?
Genes encoding deacetylases such as CobB in E. coli and eukaryotic HDACs and sirtuins are involved.
Why is peptidyl-lysine deacetylation important?
It regulates protein function and has been linked to antibiotic resistance and other cellular processes.
How can I study peptidyl-lysine deacetylation?
You can use CRISPR knockout, point mutations, proteomics, and biochemical assays.
What diseases are associated with peptidyl-lysine deacetylation?
It is implicated in bacterial antibiotic resistance and, by homology, in cancer and metabolic disorders.
What is the GO ID for peptidyl-lysine deacetylation?
The GO ID is GO:0034983.
What are the synonyms for peptidyl-lysine deacetylation?
A synonym is protein lysine acetylation.
Which organisms have peptidyl-lysine deacetylation?
It is conserved from bacteria to humans.
Can CRISPR be used to study peptidyl-lysine deacetylation?
Yes, CRISPR knockout, knock-in, and overexpression models are powerful tools.
What methods measure deacetylation?
Mass spectrometry, Western blot, and in vitro assays are commonly used.
Conclusion
Peptidyl-lysine deacetylation (GO:0034983) is a conserved and dynamic process that reverses lysine acetylation, thereby regulating protein function and cellular physiology. Its role in antibiotic resistance highlights its potential as a therapeutic target, while its conservation suggests broad relevance across biology. Continued research using CRISPR and advanced proteomics will further illuminate its mechanisms and disease connections.
References
- 1. Fang Z et al.. 2022. Potential Role of Lysine Acetylation in Antibiotic Resistance of Escherichia coli.. mSystems 7(6):e0064922 PMID: 36286553
